Divalproex Sodium for Prevention of Migraine
The use of divalproex sodium (DVS) as a prophylactic treatment for migraine was studied in 42 patients, 7 to 16 years of age (mean age, 11.3 years) seen between July 1996 and December 1998 at St Jude Children’s Research Hospital, Memphis, TN; and Hasbro Children’s Hospital/Rhode Island Hospital,Diva...
Uloženo v:
| Hlavní autor: | |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Pediatric Neurology Briefs Publishers
2000-11-01
|
| Edice: | Pediatric Neurology Briefs |
| Témata: | |
| On-line přístup: | https://www.pediatricneurologybriefs.com/articles/1843 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|